Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

… Criteria, Significantly Reduce Data Collection, Researcher Says … Erin Jungmeyer …

Comprehensive Analysis of Proteomics Identifies New, Druggable Drivers of NSCLC—and New Avenue for Continued Research

… Druggable Drivers of NSCLC—and New Avenue for Continued Research … Beth Fand Incollingo …

Passing of The Baton—On the Death of Patient Research Advocates

The Peaks and Valleys in Lung Cancer Therapeutics Research

… The Peaks and Valleys in Lung Cancer Therapeutics Research …

Food as Medicine: Research Aims to Understand the Power of Nutrition in Treating Cancer

… microbiome in immunotherapy efficacy. … Food as Medicine: Research Aims to Understand the Power of Nutrition in Treating …

Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A With Dr. Benjamin Movsas

… Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A …

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …

Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy

… of ADCs with TKIs. 18  Learn more about the latest in ADC research here. Physicians and patients alike question which … failure of EGFR-TKI therapy. Translational Lung Cancer Research. 2021;10(9):3782-92. 7.  Itchins M, Ainsworth H, … COMPARING OUTCOMES OF VARIOUS TREATMENT REGIMENS IN THE SEARCH FOR THE BEST-PERFORMING APPROACH. … Challenges of …

A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib

… in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards … in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards …

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

… at correlating with event-free and overall survival. Researchers have a digital platform and AI algorithm to … with large trials have agreed to contribute their data.” Researchers will be looking to see if pCR leads to long-term …

Should Biomarkers Be Used in the Clinical Management of ES-SCLC?

… not there yet. We can’t force it.” He said having recent research that has demonstrated the heterogeneity of SCLC is a huge first step. As is other recent research showing that liquid biopsy can be used to identify …

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …